HSIC logo

HENRY SCHEIN INC

HSICNASDAQ
πŸ† #900 by market capUS Equity
$342.46β–Ό $9.90 (βˆ’2.89%)
Simulated price
πŸ””
Track HSIC
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 2.9%
7dβ–² 291.7%
14dβ–² 291.3%
30dβ–² 282.5%
ytdβ–² 353.0%
1yβ–² 418.6%
🏦Market Cap
$9.84B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+4.0%
Slowing
πŸ“ŠGross Margin
30.3%
Moderate
πŸ’΅FCF Margin
4.0%
Moderate
βš–οΈP/S Ratio
0.7x
Cheap
Otter Score
76
Good

Trading Snapshot

Day Range
$338.19 – $346.12
52-Week Range
$61.95 – $92.18
Volume
$2.58B
Avg Volume
$2.26B
Shares Outstanding
113.9M
Next Earnings
Oct 19, 2026

Fundamentals Snapshot

Annual Revenue
$13.60B
Last Q Revenue
$3.79B
P/E Ratio
25.0
P/S Ratio
0.7x
EPS (TTM)
$3.55
Dividend Yield
0.00%
Dilution (1yr)
βˆ’5.8%

Why Investors Own HSIC

  • βœ“High-growth profile β€” revenue up +15.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 62% gross margin and 23% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

HSIC logo

HENRY SCHEIN INC

HSIC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$13.2Bβ–² +4.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
29.1%β–Ό βˆ’1.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$758Mβ–² +4.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$573Mβ–Ό βˆ’13.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
118.3Mβ–Ό βˆ’5.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$3.5Bβ–Ό βˆ’$783M YoY
StockOtter Β· stockotter.space

About HENRY SCHEIN INC

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
76/100

Analyst Price Target

β“˜
Average Target
$431.12
β–² +25.9% Upside
High Target$478.70
Low Target$363.30
Based on 39 analysts

Latest News & Updates